As targeting IGFBP5 significantly prolonged the survival of mice bearing orthotopic GBM, we may shine more light on a potentially promising therapeutic approach to greatly increase the life expectancy of patients with GBM, particularly those with a poor prognosis related to GBM invasion or reoccurrence. Here, IGFBP5 is linked to glioblastoma.